Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Methyl 2 (5 bromo 4 (1 cyclopropylnaphthalen 4 yl) 4H 1,2,4 triazol 3 ylthio)acetate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.